Technology | PACS Accessories | October 24, 2016

GE Showcasing Analytics and Dose Monitoring Software at RSNA 2016

Asset Performance Management helps users analyze data to improve operations; DoseWatch Explore allows tracking, analysis and reporting of practice level CT dose data

GE Healthcare, DoseWatch Explore, Asset Performance Management, APM, big data, RSNA 2015

October 24, 2016 — GE Healthcare will show its latest software solutions for data analytics and dose monitoring at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago.

Big data is everywhere and in healthcare, it is a reference to the vast amount of structured and unstructured data being created. But just capturing that data is no longer good enough. The key to extracting value from big data is to identify and analyze relevant and actionable information points that drive decision making. GE introduced Asset Performance Management (APM) software to help with this task.

Maximizing the potential of data and analytics in healthcare is key to reducing waste, increasing financial viability for providers and offering a better patient experience through strategic analysis and process improvement. Unlocking these new insights with applications at all levels of the healthcare operation can impact levers such as reducing unplanned downtime, increasing throughput, attaining higher asset utilization, better asset lifecycle management and increasing clinical effectiveness.

Beyond improving profits and cutting down on wasted overhead, the use of data and analytics in healthcare will help organizations focus on population health, curing disease, improving quality of life and avoiding preventable deaths. Models of treatment delivery are rapidly changing, and many of the decisions behind those changes are being driven by data.

GE Healthcare Global Services’ Asset Performance Management solutions help customers connect their data to actionable insights that can enhance asset performance and utilization, driving clinical, financial and operational outcomes for sustainable success. The software allows users to unlock new insights from historical data and more recent performance indicators to adapt delivery model, drive clinical, financial and operational outcomes.

On the dose monitoring side is DoseWatch Explore, a Web-based, cloud-deployed, introductory dose management software to track, analyze and report practice-level data for GE computed tomography (CT) systems. DoseWatch Explore provides visibility to practice level dose data, an affordable program with no IT integration and an automated tool for dose data and analytics.

The software ties in to the company’s Dose Excellence Program of consulting and educational services to help customers accelerate improvement, from measuring and tracking radiation dose to managing it. Our experts will help them create a dose team and customize a multi-step plan aimed at reducing variation, managing risk, streamlining reporting and enabling quality imaging at the lowest dose possible.

GE Healthcare’s technology-based MR [magnetic resonance] Performance Excellence solutions are aimed at assisting customers in improving productivity through two key offerings: first, MR Performance Assessment, which will be designed to focus on data acquisition and analysis of operational workflow and second, MR Performance Excellence Services, which will be designed to help enable customized advisory based on workflow data assessment, interpretation and analysis.

For more information: www.gehealthcare.com

Related Content

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur
In today’s challenging healthcare environment, radiology departments are often faced with the difficult decision of how to safely image patients who are suspected of being positive with infectious disease. To help hospitals and institutions effectively utilize computed tomography (CT) with these conditions, Canon Medical Systems USA, Inc. introduces a deployable CT with a rapid decontamination solution.
News | Computed Tomography (CT) | May 11, 2020
May 11, 2020 — In today’s challenging healthcare environment, radiology departments are often faced with the difficul
Axial (A) and coronal (B) CT of the abdomen and pelvis with IV contrast in a 57-year-old man with a high clinical suspicion for bowel ischemia. There was generalized small bowel distension and segmental thickening (arrows), with adjacent mesenteric congestion (thin arrow in B), and a small volume of ascites (* in B). Findings are nonspecific but suggestive of early ischemia or infection.

Axial (A) and coronal (B) CT of the abdomen and pelvis with IV contrast in a 57-year-old man with a high clinical suspicion for bowel ischemia. There was generalized small bowel distension and segmental thickening (arrows), with adjacent mesenteric congestion (thin arrow in B), and a small volume of ascites (* in B). Findings are nonspecific but suggestive of early ischemia or infection. Image courtesy of RSNA

News | Coronavirus (COVID-19) | May 11, 2020
May 11, 2020 — Patients with COVID-19 can have b